Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Register today to learn more
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / Decrease BRD Re-treatments. Decrease Losses.
Three ways eliminating extra pulls and re-treatments helps improve your returnsBy John Pollreisz, DVM, Beef Technical Services, Zoetis
It’s simple to look at your profit and loss statement and see exactly how much you are spending on treatment medications for bovine respiratory disease (BRD). But BRD could be impacting more areas of your profit and loss, especially if you don’t treat it effectively. These other costs aren’t as easy to see, but they often represent a more significant part of the equation.
A recent meta-analysis conducted by Iowa State University shows that some injectable BRD antibiotic treatments could be causing approximately two to five times more re-treats on your operation compared with more effective treatment options.1,* This means you could be purchasing at least twice as many antibiotics, having your labor administering twice as many treatments and having nearly twice as many prolonged BRD cases that can negatively impact gain, feed efficiency, carcass quality grade, hot carcass weight, carcass yield grade and, ultimately, your net revenue.
Reducing unneeded re-treats on your operation is one way to help reduce significant impacts to performance and your profits. Here are three ways this can help:
It’s no secret that when cattle are healthy, they eat, gain and convert better. Even subtle changes in feeding behavior can have a big impact on performance and carcass value. Average daily gain (ADG) can change depending on time of year, number of pulled cattle that were repulled, borderline chronics and how many days the cattle were fed, but one study found an impact of an approximately 0.2 pound loss in ADG with each additional treatment for BRD.2,** In my experience, I believe that this value often underestimates the impact more BRD re-treatments have on ADG.
You won’t feed cattle your worst feed. Your BRD treatment shouldn’t be any different. By starting with a more effective antibiotic, or rather improving your first-treatment success, your healthier cattle can be on your best feed for less time and gain weight — and your overall profits — more effectively.
More BRD management advice and information about cost-effective solutions for treating BRD, including Draxxin® (tulathromycin) Injectable Solution is available at BRD-Solutions.com.
IMPORTANT SAFETY INFORMATION: Draxxin has a pre-slaughter withdrawal time of 18 days in cattle. Do not use in female dairy cattle 20 months of age or older. Do not use in animals known to be hypersensitive to the product. See full Prescribing Information.
About the authorJohn “J.P.” Pollreisz is a managing veterinarian with Zoetis Beef Technical Services and has been with Zoetis since 1992 (then SmithKline Beecham). In his current role, Dr. Pollreisz is focused on and passionate about prevention and control of bovine respiratory disease and integrated health and performance management throughout the beef production chain — from ranch to feedlot finishing.
Dr. Pollreisz grew up on a small beef and horse farm in Illinois and received his Doctor of Veterinary Medicine from the University of Illinois in 1985. Prior to joining Zoetis, he served as a staff veterinarian at an integrated ranching, feedlot and packing plant operation in western Nebraska; as a veterinarian at a mixed animal practice in Fairbury, Nebraska; and as a consulting veterinarian for Palo Duro Veterinary Services in Canyon, Texas, helping backgrounding and feeding operations across Texas, Oklahoma, Kansas, Illinois and Wisconsin. He is a member of the Academy of Veterinary Consultants and previously served on their board of directors and as the first appointee for their National Cattlemen’s Association Beef Quality Assurance Task Force, which began in 1991, for the first three years of the task force.
About Zoetis Zoetis (NYSE: ZTS) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2017, the company generated annual revenue of $5.3 billion with approximately 9,000 employees. For more information, visit www.zoetisUS.com.
For more information, contact:Kathleen McGintyZoetis973email@example.com
Lindsey LangemeierBader Rutter402firstname.lastname@example.org
References:*Based on a meta-analysis,1 Bio-Mycin® (oxytetracycline injection) has a relative risk of re-treatment at 4.44,† Micotil® (tilmicosin) has a relative risk of re-treatment of 1.87,† Zuprevo® (tildipirosin) is 1.95† and Zactran® (gamithromycin) is 1.88† compared with 1.00† for Draxxin® (tulathromycin) Injectable Solution for BRD treatment.**In a study, cattle treated zero, one, two or more than two times had ADG of 3.23, 3.00, 2.83 and 2.73 pounds/day, respectively. This is a difference of approximately 0.2 pound.2***In one study published in 2013, cattle treated twice returned a profit of $1.93, whereas cattle treated only once for BRD returned a profit of $17.79, or a difference of $15.86.3†Not based on clinical outcomes1 O’Connor AM, Yuan C, Cullen JN, Coetzee JK, da Silva N, Wang C. A mixed treatment meta-analysis of antibiotic treatment options for bovine respiratory disease — An Update. Prev Vet Med. 2016;132:130-139.2 Brooks KR, Raper KC, Ward CE, Holland BP, Krehbiel BP, Step DL. Economic effects of bovine respiratory disease on feedlot cattle during backgrounding and finishing phases. Prof Anim Sci. 2011;27(3):195-203.3 Cernicchiaro N, White BJ, Renter DG, Babcock AH. Evaluation of economic and performance outcomes associated with the number of treatments after an initial diagnosis of bovine respiratory disease in commercial feeder cattle. Am J Vet Res. 2013;74(2):300-309.
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved.